These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16613383)

  • 21. [Creativity and antipsychotic drugs].
    Murry P; Torrecuadrada JL
    Encephale; 1997 Sep; 23 Spec No 4():17-9. PubMed ID: 9417399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sector user and provider perceptions on experiences of shared-care clozapine: a qualitative study.
    Sowerby C; Taylor D
    BMJ Open; 2017 Sep; 7(9):e017183. PubMed ID: 28963298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical follow-up -- EEG -- serum determinations: therapeutic experience with clozapine].
    Gekiere F; Dessalles MC; Poisson N; Maitre L
    Encephale; 1996 Dec; 22 Spec No 6():16-23. PubMed ID: 9102314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia.
    Rodriguez VM; Catalina ML; García-Noblejas JA; Cuesta P
    Psychiatry Res; 1998 Jan; 77(1):21-8. PubMed ID: 10710171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine in schizophrenia.
    Judge J
    Psychiatr Serv; 1999 Aug; 50(8):1087. PubMed ID: 10445662
    [No Abstract]   [Full Text] [Related]  

  • 30. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 31. Addressing nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Feb; 73(2):e07. PubMed ID: 22401484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse in clozapine-treated schizophrenic patients.
    Sand PG; Soyka M
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):626-7. PubMed ID: 9447510
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of life of schizophrenic patients and clozapine].
    Raoul Y; Manesse P; Delage M
    Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients.
    Masoudzadeh A; Khalilian AR
    Pak J Biol Sci; 2007 Dec; 10(23):4287-90. PubMed ID: 19086588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Violence and schizophrenia: clozapine as a specific antiaggressive agent.
    Buckley P; Bartell J; Donenwirth K; Lee S; Torigoe F; Schulz SC
    Bull Am Acad Psychiatry Law; 1995; 23(4):607-11. PubMed ID: 8639988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.
    Qurashi I; Collins JD; Chaudhry IB; Husain N
    J Psychopharmacol; 2014 Jul; 28(7):707-8. PubMed ID: 24646811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Families' perspectives of clozapine treatment.
    Stebbin HT
    Perspect Psychiatr Care; 1995; 31(4):14-8; quiz 19-20. PubMed ID: 8552464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of clozapine in oneroid state.
    Mendhekar DN
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):85-6. PubMed ID: 17308234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.